Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death

22 Aug 2015

Abstract excerpt

// Aleksandra A. Pandyra 1, 2, 4 , Peter J. Mullen 1 , Carolyn A. Goard 1, 2 , Elke Ericson 3, 5 , Piyush Sharma 4 , Manpreet Kalkat 1, 2 , Rosemary Yu 1, 2 , Janice T. Pong 1, 2 , Kevin R. Brown 3 , Traver Hart 3 , Marinella Gebbia 3 , Karl S. Lang 4 , Guri Giaever 3, 6 , Corey Nislow 3, 6 , Jason Moffat 3 , Linda Z. Penn 1, 2 1 Princess Margaret Cancer Centre, Toronto, ON, Canada 2 Department of Medical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Lipoproteins and Cardiovascular Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26353928
DOI: 10.18632/oncotarget.4817

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell deathPMID 26353928Read ↗

Mevalonate Pathway and Human Cancers.Semantic proximity Read ↗

Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinomaSemantic proximity Read ↗

In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cellsSemantic proximity Read ↗

Computational pharmacogenomic screen identifies drugs that phenocopy dipyridamole and potentiate anti-breast cancer activity of statinsSemantic proximity Read ↗

Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapiesSemantic proximity Read ↗

Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer InterventionsSemantic proximity Read ↗

Lipophilic statins antagonistically alter the major epithelial‐to‐mesenchymal transition signaling pathways in breast cancer stem–like cells via inhibition of the mevalonate pathwaySemantic proximity Read ↗

DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.Semantic proximity Read ↗

Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myelomaSemantic proximity Read ↗

Targeting Mevalonate Pathway Enhances the efficacy of 5-Fluorouracil by regulating pyroptosisSemantic proximity Read ↗

Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.Semantic proximity Read ↗

Statins are potential anticancerous agents (Review)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.